Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma

Autor:	A, Lipton, H A, Harvey, B, Lawrence, R, Gottlieb, M, Kukrika, R, Dixon, W, Graham, S, Miller, R, Heckard, D, Schelzel, D S, White
Rok vydání:	1983
Předmět:	Male Skin Neoplasms Time Factors Propionibacterium Middle Aged Random Allocation Evaluation Studies as Topic Recurrence Bacterial Vaccines BCG Vaccine Humans Female Melanoma Neoplasm Staging
Zdroj:	Cancer. 51(1)
ISSN:	0008-543X
Popis:	One-hundred and sixteen patients with Stage I and Stage II malignant melanoma were randomized to treatment with either Bacillus Calmette-Guerin (BCG) (Tice) or subcutaneous Corynebacterium parvum (Burroughs-Wellcome). Life table analysis failed to reveal a difference between these two forms of treatment in 68 Stage I patients. The relapse rate was significantly reduced in Stage II patients treated with C. parvum.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::593bfe8cbd54851390c4e7edbf11bc39 https://pubmed.ncbi.nlm.nih.gov/6821809 Zobrazit plný text záznamu Plný text